BibTex RIS Kaynak Göster

Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması

Yıl 2008, Cilt: 39 Sayı: 2, 56 - 62, 20.07.2014

Nuren Beşe Kimia Çepni İsmail Çepni Basri Günhan Ayşe Koca Songül Karaçam Didem Öksüz

Anahtar Kelimeler

Hodgkin hastalığı fetal doz radyoterapi

Kaynakça

  • Kal HB, Struikmans H. Radiotherapy during pregnan- cy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
  • Tewari KS. Cancer in pregnancy. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 7th ed. Mosby: Elsevier; 2007: 468-531.
  • Pavlidis NA. Coexistence of pregnancy and malignan- cy. Oncologist 2002; 7: 279- 287.
  • Hall EJ, Giaccia AJ. Effects of radiation on the embryo and fetus. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott; 2006; 168-180.
  • Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymhoma in pregnancy. Haematologica 2007; 92: 1230-1237.
  • Hoppe RT. Hodgkin’s disease. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles and practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004: 2043-2063.
  • Diehl V, Brillant C, Engert A, et al. HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol (Meeting Abstracts) 2005; 23: 6506.
  • Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat.Oncol Biol Phys. 1992; 23: 407- 412.
  • Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother 2002; 6: 352-357.
  • Zucali R, Marchesini R, De Palo G. Abdominal dosimetry for supradiaphragmatic irradiation of Hodgkin’s disease in pregnancy: experimental data and clinical consideration. Tumori 1981; 67: 203-208.
  • Nisce LZ, Tome MA, He S, et al. Management of coex- isting Hodgkin’s disease and pregnancy. Am J Clin Oncol 1986; 9: 146-151.
  • Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol 2003; 66: 333-339.
  • Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin’s disease. Med Dosim 1997; 22: 135-137.
  • International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000; 30: 1-43.
  • International Commission on Radiological Protection. Biological effects after prenatal irradiation(embryo and fetus). Ann ICRP 2003; 33: 205-206.
  • Hammer-Jacobsen E. Therapeutic abortion on account X-ray examination during pregnancy. Dan Med Bull 1959; 6: 113-122.
  • Wagner LK, Lester RG, Saldana LR. Exposure of the pregnant patient to diagnostic radiations. 2nd ed. Madison, Wisconsin: Medical Physics Publishing; 1997.
  • Stovall M, Blackwell CR, Cundiff J, Novack DH, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group no: 36. Med Phys 1995; 22: 63-82.
  • Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 1992; 65: 114-117.
  • Sneed PK, Albright NW, War WM, et al. Fetal dose esti- mates for radiotherapy of brain tumors during pregnan- cy. Int J Radiat Oncol Biol Phys 1995; 32: 823-830.
  • Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 995-999.
  • Greskovich JF, Macklis RM. Radiation therapy in preg- nancy: risk calculation and risk minimization. Seminars in Oncology 2000; 27: 633-645.
  • Ioachim HL. Non-Hodgkin’s lymphoma in pregnancy: three cases and review of the literature. Arch Pathol Lab Med 1985; 109: 803-809.

Yıl 2008, Cilt: 39 Sayı: 2, 56 - 62, 20.07.2014

Nuren Beşe Kimia Çepni İsmail Çepni Basri Günhan Ayşe Koca Songül Karaçam Didem Öksüz

Kaynakça

  • Kal HB, Struikmans H. Radiotherapy during pregnan- cy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
  • Tewari KS. Cancer in pregnancy. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 7th ed. Mosby: Elsevier; 2007: 468-531.
  • Pavlidis NA. Coexistence of pregnancy and malignan- cy. Oncologist 2002; 7: 279- 287.
  • Hall EJ, Giaccia AJ. Effects of radiation on the embryo and fetus. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott; 2006; 168-180.
  • Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymhoma in pregnancy. Haematologica 2007; 92: 1230-1237.
  • Hoppe RT. Hodgkin’s disease. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles and practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004: 2043-2063.
  • Diehl V, Brillant C, Engert A, et al. HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol (Meeting Abstracts) 2005; 23: 6506.
  • Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat.Oncol Biol Phys. 1992; 23: 407- 412.
  • Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother 2002; 6: 352-357.
  • Zucali R, Marchesini R, De Palo G. Abdominal dosimetry for supradiaphragmatic irradiation of Hodgkin’s disease in pregnancy: experimental data and clinical consideration. Tumori 1981; 67: 203-208.
  • Nisce LZ, Tome MA, He S, et al. Management of coex- isting Hodgkin’s disease and pregnancy. Am J Clin Oncol 1986; 9: 146-151.
  • Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol 2003; 66: 333-339.
  • Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin’s disease. Med Dosim 1997; 22: 135-137.
  • International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000; 30: 1-43.
  • International Commission on Radiological Protection. Biological effects after prenatal irradiation(embryo and fetus). Ann ICRP 2003; 33: 205-206.
  • Hammer-Jacobsen E. Therapeutic abortion on account X-ray examination during pregnancy. Dan Med Bull 1959; 6: 113-122.
  • Wagner LK, Lester RG, Saldana LR. Exposure of the pregnant patient to diagnostic radiations. 2nd ed. Madison, Wisconsin: Medical Physics Publishing; 1997.
  • Stovall M, Blackwell CR, Cundiff J, Novack DH, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group no: 36. Med Phys 1995; 22: 63-82.
  • Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 1992; 65: 114-117.
  • Sneed PK, Albright NW, War WM, et al. Fetal dose esti- mates for radiotherapy of brain tumors during pregnan- cy. Int J Radiat Oncol Biol Phys 1995; 32: 823-830.
  • Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 995-999.
  • Greskovich JF, Macklis RM. Radiation therapy in preg- nancy: risk calculation and risk minimization. Seminars in Oncology 2000; 27: 633-645.
  • Ioachim HL. Non-Hodgkin’s lymphoma in pregnancy: three cases and review of the literature. Arch Pathol Lab Med 1985; 109: 803-809.
Toplam 23 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Araştırmalar
Yazarlar

Nuren Beşe Bu kişi benim

Kimia Çepni Bu kişi benim

İsmail Çepni Bu kişi benim

Basri Günhan Bu kişi benim

Ayşe Koca Bu kişi benim

Songül Karaçam Bu kişi benim

Didem Öksüz Bu kişi benim

Yayımlanma Tarihi 20 Temmuz 2014
Yayımlandığı Sayı Yıl 2008 Cilt: 39 Sayı: 2

Kaynak Göster

APA Beşe, N., Çepni, K., Çepni, İ., Günhan, B., vd. (2014). Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi, 39(2), 56-62.
AMA Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi. Temmuz 2014;39(2):56-62.
Chicago Beşe, Nuren, Kimia Çepni, İsmail Çepni, Basri Günhan, Ayşe Koca, Songül Karaçam, ve Didem Öksüz. “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”. Cerrahpaşa Tıp Dergisi 39, sy. 2 (Temmuz 2014): 56-62.
EndNote Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D (01 Temmuz 2014) Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi 39 2 56–62.
IEEE N. Beşe, K. Çepni, İ. Çepni, B. Günhan, A. Koca, S. Karaçam, ve D. Öksüz, “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”, Cerrahpaşa Tıp Dergisi, c. 39, sy. 2, ss. 56–62, 2014.
ISNAD Beşe, Nuren vd. “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”. Cerrahpaşa Tıp Dergisi 39/2 (Temmuz 2014), 56-62.
JAMA Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi. 2014;39:56–62.
MLA Beşe, Nuren vd. “Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması”. Cerrahpaşa Tıp Dergisi, c. 39, sy. 2, 2014, ss. 56-62.
Vancouver Beşe N, Çepni K, Çepni İ, Günhan B, Koca A, Karaçam S, Öksüz D. Hodgkin Hastalığı Mantle Işınlamasında Fetus Dozlarının Araştırılması. Cerrahpaşa Tıp Dergisi. 2014;39(2):56-62.